ArticleJournal of cancer immunology2024

Combining EGFR and KRAS G12C Inhibitors for KRAS G12C Mutated Advanced Colorectal Cancer.

Hirotaka Miyashita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.